GSK joins NASH chase, paying $120M up front for rights to Arrowhead RNAi drug
14 days ago - By MedCity News
GlaxoSmithKline sees enough promise in the early clinical data of a novel NASH drug to pay its developer, Arrowhead Pharmaceuticals, $120 million up front for rights to the experimental therapy. The Arrowhead drug uses RNA interference to “silence” an enzyme associated with the progression of the fatty liver disease.
Read more ...
The headlines of Care Mag
3 Aesthetic Eyedrops Pros Recommend
The latest eye drops that help bring your brightest features forward.
Tarte Is Adding an SPF Cream to the Shape Tape Line
The newest addition to Tarte's shape tape™ line.
A Facial Trainer Explains How to Sculpt Your Face at Home
Lifting and sculpting from your own home isn't as hard as it sounds.
6 Beauty and Wellness Trends We'll See Everywhere in 2022
According to Pinterest.
DNA Storage in a Yottabyte Era
By KIM BELLARD Did you know we are living in the Zettabyte Era? Honestly, did you even know what a zettabyte is? Kilobytes, gigabytes, maybe even terabytes, sure, but...
A Hospital's Holiday Party Turned Into a Superspreader Event-Here's How
Superspreaders continue to be a thing.
A first, small study suggests Omicron is a larger threat to Covid-19...
A small, preliminary study has found a significant drop in how well vaccine-elicited antibodies target the Omicron variant of the coronavirus. But the variant did not...
Hearing Aid Dome: Purpose, Types, Benefits
One of the greatest challenges for people who struggle with hearing loss is finding an adequate listening device. Back in the day, they used to rely on a hearing trumpet to...
How an Eye Doctor Can Help With Dry Eyes
Millions of people around the world are suffering from dry eyes. If you are one of the people who feel like there is sand stuck in them, this article is for you. This article...
Everything You Need to Know About Short-Term Disability As An Employer
As an employer, it's your responsibility to ensure that your employees are happy and healthy at work. Part of your role as an employer will involve following the necessary...